Delivery Order SPE2DB20D9354-SPE2DB24FX7M5

Award Date 2/21/24
Potential Completion Date 3/13/24
Potential Value $6.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The contract is valued at $6,729.00 and has a completion date of March 12, 2024. DMS Pharmaceutical Group will provide NUPLAZID 34 MG CAPSULE 30S to fulfill the agency's pharmaceutical supply needs. This contract is not associated with a set-aside program. DMS Pharmaceutical Group...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,375.53 contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through February 24, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, allowing the agency to issue delivery...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract, valued at $10,093.50, to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S to support the medical supply needs of the agency. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery contract, SPE2DB, with the Defense Logistics Agency, which has a potential value...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,093.50, is for the delivery of the prescription drug NUPLAZID 34 MG CAPSULE 30S. The contract has an ultimate completion date of July 31, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $3,458.51 and covers the delivery of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, with a performance period through March 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of various pharmaceutical products including NUPLAZID 34 MG CAPSULE 30S. The contract, valued at $6,729.00, has an ultimate completion date of September 19, 2024. DMS Pharmaceutical Group provides a wide range of pharmaceutical items, from common medications to specialized drugs and medical supplies, to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,093.50 firm fixed-price contract is for the delivery of 4564884983 - NUPLAZID 34 MG CAPSULE 30S, with a performance period through July 3, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
This contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $3,364.50 for the pharmaceutical product NUPLAZID 34 MG CAPSULE 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on November 6, 2024, with a completion date of November 29, 2024. The contract is a firm fixed-price delivery order and is not associated with any set-aside...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the supply of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, at a ceiling value of $10,093.50. The award has an ultimate completion date of November 19, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,364.50 firm fixed-price contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a prescription medication. The contract has a period of performance through November 19, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB24FX7M5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, with a potential value of $6,729.00 and a completion date of March 13, 2024. The contract type is Firm Fixed Price. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Veterans Affairs and the Department of Defense. This contract is not associated with a set-aside program.

Generated 5/22/24, 10:17 AM